Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.

Lyon PC. et al, (2019), Ultraschall Med

Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.

Gray MD. et al, (2019), Radiology

Long-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancer.

Lyon PC. et al, (2018), Radiol Case Rep, 13, 1259 - 1266

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.

Lyon PC. et al, (2018), Lancet Oncol, 19, 1027 - 1039

High-intensity focused ultrasonic ablation of sacral chordoma is feasible: a series of four cases and details of a national clinical trial.

Gillies MJ. et al, (2017), Br J Neurosurg, 31, 446 - 451

Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.

Lyon PC. et al, (2017), J Ther Ultrasound, 5

TARDOX: Safety and Feasibility of Targeted Delivery of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) By Focused-Ultrasound Hyperthermia for Liver Tumours

Odondi LET. et al, (2016)

Planning and Delivery of Ultrasound- Mediated Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial

MIDDLETON MR. et al, Radiology

Include forthcoming?